MEGAVAC INJ
MEGAVAC INJ
Discontinued
DIN Number
00316393
Drug Class
Human
Market Date
Dec 31, 1974
Company
HC
omega laboratories limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00316393
AIG Number0909995001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07AX OTHER BACTERIAL VACCINES
Product Specifications
Dosage FormLiquid
Route of AdministrationSubcutaneous
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (9)
HEMOPHILUS INFLUENZAEActive
Strength: 75 M / ML
Monograph: HEMOPHILUS INFLUENZAE
KLEBSIELLA PNEUMONIAEActive
Strength: 75 M / ML
Monograph: KLEBSIELLA PNEUMONIAE
NEISSERIA CATARRHALISActive
Strength: 75 M / ML
Monograph: NEISSERIA CATARRHALIS
PNEUMOCOCCUS (VARIOUS TYPES MIXTURE)Active
Strength: 75 M / ML
Monograph: PNEUMOCOCCUS (VARIOUS TYPES MIXTURE)
STAPHYLOCOCCUS ALBUSActive
Strength: 300 M / ML
Monograph: STAPHYLOCOCCUS ALBUS
STAPHYLOCOCCUS AUREUSActive
Strength: 300 M / ML
Monograph: STAPHYLOCOCCUS AUREUS
STREPTOCOCCUS NON-HEMOLYTICActive
Strength: 33 M / ML
Monograph: STREPTOCOCCUS NON-HEMOLYTIC
STREPTOCOCCUS PYOGENESActive
Strength: 33 M / ML
Monograph: STREPTOCOCCUS PYOGENES
STREPTOCOCCUS VIRIDANSActive
Strength: 33 M / ML
Monograph: STREPTOCOCCUS VIRIDANS